Dr. Christopher M. Duma, MD

Dr. Duma practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Dr. Duma's NPI, 1306870845, was assigned on July 10, 2006. Dr. Duma graduated from Renaissance School of Medicine at Stony Brook University in 1986. Dr. Duma holds California license G76797.

Dr. Duma's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Dr. Duma also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Dr. Duma's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Duma to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duma practices, 4 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Duma's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Duma's licenses on file in 3 states: California, Nevada and Pennsylvania.

Dmand AI lists craniotomy among the conditions Dr. Duma treats.

CMS data shows 1,389 Medicare services from Dr. Duma across 22 procedure codes in 2024, for 488 Medicare patients. Medicare paid $288,422 for them.

CMS counts 488 Medicare patients who saw Dr. Duma in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Duma's median patient age at 76, with 58% women.

In 2024, Dr. Duma wrote 58 Medicare Part D claims. 86% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $62 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 31 out of 100 for Dr. Duma for performance year 2024, reported individually. Dr. Duma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Duma as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 54 papers to Dr. Duma, published from 2007 to 2022. 2015 was the busiest year, with 4. The most frequent topics are Radiosurgery, Brain Neoplasms and Magnetic Resonance Imaging. Dr. Duma has published most often in J Neurosurg. Dr. Duma's most frequent co-authors are Peter Vun Chen, MD, Robert O. Dillman, MD, FACP and John C. Flickinger, MD.

Dmand AI links Dr. Duma to 3 clinical trials. Conditions studied include Glioblastoma, Neuritis and Astrocytoma.

CMS Open Payments shows 362 general payments to Dr. Duma from 36 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 77% of the total. Longeviti Neuro Solutions LLC paid the most, $126,111.

Dmand AI lists 4 awards for Dr. Duma.

Dr. Duma graduated from Renaissance School of Medicine at Stony Brook University in 1986. Dr. Duma is a member of AANS, ACS, CNS and MDS.

Dr. Duma is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.